Safety of Minilaparotomy Provided by Trained Clinical Officers and Assistant Medical Officers: a Non-inferiority Trial

NCT ID: NCT02944149

Last Updated: 2017-08-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1970 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-12-31

Study Completion Date

2017-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is a non-inferiority randomized controlled trial (RCT) that aims to demonstrate that tubal ligations by minilaparotomy (ML) conducted by trained clinical officers (COs) are no less safe as compared to those conducted by assistant medical officers (AMOs) in Tanzania. Participants will be randomized in a one to one ratio to ML by a CO and ML by an AMO. In addition to the screening and enrollment/ML visit, there will be three scheduled follow-up visits at 3, 7 and 42 days post-surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary objective is to establish whether the safety of ML provided by trained COs is not inferior to the safety of ML provided by trained AMOs, as measured by rates of major adverse events (AEs) among women undergoing ML. The primary outcome is safety, defined by the overall rate of major AEs following ML. The investigators will address the primary objective by comparing the rate of major AEs observed following MLs conducted by COs vs. AMOs during the ML procedure and through 42 days follow-up. This study will be conducted among 1,970 women 18 years of age and older presenting at study sites for ML surgery. The duration of a woman's participation in the study is expected to be 6 weeks, unless additional follow-up beyond 42 days is clinically indicated due to complications or for other reasons. The study will be conducted in Arusha Region in northern Tanzania. The following health facilities will serve as study sites: Daraja Health Centre, Karatu Hospital, Kaloleni Health Centre, Levolosi Urban Health Centre, Longido Health Centre, Monduli Hospital, and Mto wa Mbu Health Centre.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sterilization, Tubal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

assistant medical officer (AMO)

Assistant medical officers (AMO) are currently allowed to provide tubal ligation by minilaparotomy, however government regulations do not allow clinical officers (COs) to provide this service.

Group Type ACTIVE_COMPARATOR

tubal ligation by minilaparotomy

Intervention Type PROCEDURE

Tubal ligation will be performed by minilaparotomy as per the Tanzanian government standards, with the standard family planning counseling and minilaparotomy surgical protocols used by the government being followed during the study.

clinical officer (CO)

Experimental: clinical officer (CO) In Tanzania, COs are mid-level providers who offer diagnosis, treatment, and minor surgeries. They are more common in rural areas than medical officers (MOs) and assistant medical officers (AMOs) and are generally considered capable of performing minor surgery. Almost all facilities in Tanzania are understaffed, but COs vastly outnumber MOs and AMOs. COs are more prevalent in poorer and/or rural areas than other higher level cadres; thus, task-shifting to COs would increase access to tubal ligation by minilaparotomy for many women who are most in need.

Group Type EXPERIMENTAL

tubal ligation by minilaparotomy

Intervention Type PROCEDURE

Tubal ligation will be performed by minilaparotomy as per the Tanzanian government standards, with the standard family planning counseling and minilaparotomy surgical protocols used by the government being followed during the study.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

tubal ligation by minilaparotomy

Tubal ligation will be performed by minilaparotomy as per the Tanzanian government standards, with the standard family planning counseling and minilaparotomy surgical protocols used by the government being followed during the study.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

female sterilization

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 18 years and older;
* Requested and consented to female sterilization AND additionally freely consents to participate in the study and signs a study informed consent form;
* Is sound of mind, in good general health and deemed suitable to undergo female sterilization by ML in accordance with the Tanzania government guidelines;
* Able to understand study procedures and requirements of study participation;
* Agrees to return to the study site for the full schedule of follow-up visits after her ML procedure;
* Agrees to provide the study staff with an address, phone number, close relative, and/or other locator information while participating in the research study.

Exclusion Criteria

* Pregnancy
* Between 8 and 42 days postpartum or postabortion
* Known allergy or sensitivity to lidocaine or other local anesthesia
* Takes a medication that would be a contraindication for elective surgery, such as an anticoagulant or steroid
* Previous abdominal or pelvic surgery
* Local skin infection near area where incision will be made
* Coagulation disorder
* Hypertension (properly taken measurements; systolic ≥ 160 or diastolic ≥ 100 mm Hg)
* Acute deep venous thrombosis/pulmonary embolism
* Current ischemic heart disease
* Unexplained vaginal bleeding
* Malignant gestational trophoblastic disease
* Cervical, endometrial and/or ovarian cancer
* Pelvic inflammatory disease (current or within the last three months)
* Current purulent cervicitis, chlamydial infection and/or gonorrhea
* Current symptomatic gall bladder disease
* Active viral hepatitis
* Severe anemia (irrespective of type or etiology)
* Tuberculosis of pelvic organs
* Acute bronchitis or pneumonia
* Systematic infection or gastroenteritis
* Currently participating in another biomedical research study.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tanzania Ministry of Health, Community Development, Gender, Elders, and Children

UNKNOWN

Sponsor Role collaborator

Association of Gynaecologists and Obstetricians of Tanzania

UNKNOWN

Sponsor Role collaborator

United States Agency for International Development (USAID)

FED

Sponsor Role collaborator

EngenderHealth

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mark A Barone, DVM, MS

Role: PRINCIPAL_INVESTIGATOR

EngenderHealth

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Daraja Health Centre

Arusha, Arusha, Tanzania

Site Status

Kaloleni Health Centre

Arusha, Arusha, Tanzania

Site Status

Levolosi Health Centre

Arusha, Arusha, Tanzania

Site Status

Karatu Lutheran Hospital

Kiratu, Arusha, Tanzania

Site Status

Longido Health Centre

Longido, Arusha, Tanzania

Site Status

Monduli District Hospital

Monduli, Arusha, Tanzania

Site Status

Mto Wa Mbu Health Center

Monduli, Arusha, Tanzania

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Tanzania

References

Explore related publications, articles, or registry entries linked to this study.

Barone MA, Mbuguni Z, Achola JO, Almeida A, Cordero C, Kanama J, Marquina A, Muganyizi P, Mwanga J, Ouma D, Shannon C, Tibyehabwa L. Safety of Tubal Occlusion by Minilaparotomy Provided by Trained Clinical Officers Versus Assistant Medical Officers in Tanzania: A Randomized, Controlled, Noninferiority Trial. Glob Health Sci Pract. 2018 Oct 4;6(3):484-499. doi: 10.9745/GHSP-D-18-00108. Print 2018 Oct 3.

Reference Type DERIVED
PMID: 30120168 (View on PubMed)

Barone MA, Mbuguni Z, Achola JO, Cordero C, Kanama J, Muganyizi PS, Mwanga J, Shannon C, Tibyehabwa L. Safety of tubal ligation by minilaparotomy provided by clinical officers versus assistant medical officers: study protocol for a noninferiority randomized controlled trial in Tanzanian women. Trials. 2017 Oct 26;18(1):499. doi: 10.1186/s13063-017-2235-6.

Reference Type DERIVED
PMID: 29073928 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TAN-42

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

ToT and Estrogen in Postmenopausal Females
NCT03295487 COMPLETED PHASE2/PHASE3